Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab.
De Biasi S, Mattioli M, Meschiari M, Lo Tartaro D, Paolini A, Borella R, Neroni A, Fidanza L, Busani S, Girardis M, Coppi F, Mattioli AV, Guaraldi G, Mussini C, Cossarizza A, Gibellini L.
De Biasi S, et al. Among authors: mattioli av, mattioli m.
Front Immunol. 2023 May 5;14:1123807. doi: 10.3389/fimmu.2023.1123807. eCollection 2023.
Front Immunol. 2023.
PMID: 37215114
Free PMC article.